Business Description
Alfresa Holdings Corp
ISIN : JP3126340003
Total Employee Number:
15,500Compare
Compare
Traded in other countries / regions
2784.JapanARHCF.USA IPO Date
2017-02-27Description
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.42 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.46 | |||||
Interest Coverage | 102.16 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.6 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 9.8 | |||||
3-Year Book Growth Rate | 5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.69 | |||||
9-Day RSI | 78.46 | |||||
14-Day RSI | 79.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 22.31 | |||||
Days Sales Outstanding | 80.84 | |||||
Days Payable | 114.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.09 | |||||
Dividend Payout Ratio | 0.47 | |||||
3-Year Dividend Growth Rate | 6.1 | |||||
Forward Dividend Yield % | 3.21 | |||||
5-Year Yield-on-Cost % | 3.98 | |||||
3-Year Average Share Buyback Ratio | 3.5 | |||||
Shareholder Yield % | 3.3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 7.02 | |||||
Operating Margin % | 1.17 | |||||
Net Margin % | 1.35 | |||||
EBITDA Margin % | 2.49 | |||||
FCF Margin % | 0.31 | |||||
OCF Margin % | 1.19 | |||||
ROE % | 8.51 | |||||
ROA % | 2.76 | |||||
ROIC % | 5.98 | |||||
3-Year ROIIC % | 16.65 | |||||
ROC (Joel Greenblatt) % | 30.83 | |||||
ROCE % | 11.28 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.37 | |||||
Forward PE Ratio | 15.98 | |||||
PE Ratio without NRI | 14.86 | |||||
Shiller PE Ratio | 12.39 | |||||
PEG Ratio | 1.52 | |||||
PS Ratio | 0.13 | |||||
PB Ratio | 0.79 | |||||
Price-to-Tangible-Book | 0.81 | |||||
Price-to-Free-Cash-Flow | 39.83 | |||||
Price-to-Operating-Cash-Flow | 10.37 | |||||
EV-to-EBIT | 3.58 | |||||
EV-to-EBITDA | 2.89 | |||||
EV-to-Revenue | 0.07 | |||||
EV-to-FCF | 22.96 | |||||
Price-to-GF-Value | 1.14 | |||||
Price-to-Projected-FCF | 0.84 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
Price-to-Graham-Number | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 2.5 | |||||
Earnings Yield (Greenblatt) % | 27.93 | |||||
FCF Yield % | 2.58 | |||||
Forward Rate of Return (Yacktman) % | 11.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARHCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alfresa Holdings Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20,480.026 | ||
| EPS (TTM) ($) | 1.494 | ||
| Beta | -0.0676 | ||
| 3-Year Sharpe Ratio | -60.23 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 2.5 | ||
| 14-Day RSI | 79.9 | ||
| 14-Day ATR ($) | 0.194689 | ||
| 20-Day SMA ($) | 12.355 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 11.87 - 14.59 | ||
| Shares Outstanding (Mil) | 175.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alfresa Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alfresa Holdings Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| JPY 35.000000 Cash Dividend | 2026-09-29 | In 50 days | ||
| JPY 34.000000 Cash Dividend | 2026-03-30 | 11.87 (+0.00%) | ||
| JPY 34.000000 Cash Dividend | 2025-09-29 | 11.87 (+0.00%) | ||
| JPY 32.000000 Cash Dividend | 2025-03-28 | 11.87 (+0.00%) | ||
| JPY 31.000000 Cash Dividend | 2024-09-27 | 11.87 (+0.00%) |
Show
Entries
Alfresa Holdings Corp Frequently Asked Questions
What is Alfresa Holdings Corp(ARHCF)'s stock price today?
The current price of ARHCF is $14.00. The 52 week high of ARHCF is $14.59 and 52 week low is $11.87.
When is next earnings date of Alfresa Holdings Corp(ARHCF)?
The next earnings date of Alfresa Holdings Corp(ARHCF) is .
Does Alfresa Holdings Corp(ARHCF) pay dividends? If so, how much?
The Dividend Yield %  of Alfresa Holdings Corp(ARHCF) is 3.09% (As of Today), Highest Dividend Payout Ratio of Alfresa Holdings Corp(ARHCF) was 0.53. The lowest was 0.24. And the median was 0.42. The  Forward Dividend Yield % of Alfresa Holdings Corp(ARHCF) is 3.21%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:ARHCF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan | 2026-07-29 |
Articles on Alfresa Holdings Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers